Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
January 20, 2020
Antiviral immunity survives CD19-directed therapy
From the Hill and Turtle laboratories, Vaccine and Infections Disease Division and Clinical Research Division
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Fred Hutch science and research highlights 2019
Articles showcasing some of the most significant advances in immunotherapy, cell biology and more
World AIDS Day: Stepping up the search for a cure
New funding from Gates Foundation and NIH give vote of confidence for an audacious goal
Inflammatory mucosal T cells: harmful or helpful?
From the Lund lab, Vaccine and Infectious Disease Division
Dr. Martin 'Mac' Cheever, cancer immunotherapy expert, receives distinguished service award
Honor recognizes his work establishing Cancer Immunotherapy Trials Network
Hutch influenza experts assay the latest science
Flu shots remain your best bet for protection, but no guarantee against infection
Baiting for B cells: A clever new way to make an AIDS vaccine
Researchers fish for rare blood cells that can evolve into HIV blockers
Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine
Statistician honored for helping the world anticipate, manage and prevent infectious disease outbreaks
New trial aims to curb HPV-related cancers in HIV+ women and children
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
An old HIV vaccine surprises researchers once again
Designed for a Thailand strain of the AIDS virus, it stirred stronger immunity in South Africa
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Life Sciences Research Foundation funds study to track evolution, spread of bird flu
Computational biologist and virologist Dr. Louise Moncla receives 3-year grant
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Engineering B cells to bypass vaccines
From the Taylor Lab, Vaccine and Infectious Disease Division
Dr. M. Elizabeth ‘Betz’ Halloran receives Nathan Mantel Lifetime Achievement Award
Biostatistician honored for her landmark contributions to statistical methods for infectious disease epidemiology